Talis Biomedical Corporation ( TLIS) - Key Metrics
Stock symbol TLIS is outdated, potentially delisted? Maybe it is available on other exchange?
TLIS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | ? | -$4.86 | -$6.22 | -$6.22 |
| 2024Q1 | $0.04 | -$7.15 | -$3.53 | -$3.53 |
| 2023Q4 | $0.08 | -$7.40 | -$6.24 | -$6.19 |
| 2023Q3 | $0.04 | -$8.62 | -$6.13 | -$6.16 |
| 2023Q2 | $0.03 | -$8.27 | -$7.85 | -$8.12 |
TLIS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.43 |
| 2024Q1 | ? | -0.30 |
| 2023Q4 | ? | -0.25 |
| 2023Q3 | ? | -0.17 |
| 2023Q2 | ? | -0.22 |
TLIS
Price: $2.84
52 week price:
Earnings Per Share: -28.02 USD
P/E Ratio: -0.10
Exchange: OEM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 73600
Market Capitalization: 5.2 million